MTT assays verified that overexpression of TMEM92‐AS1 can promote the proliferation of gastric cancer cells, knockdown of CCL5 can inhibit proliferation, and overexpression of TMEM92‐AS1 can accelerate the sluggish proliferation rate caused by knockdown of CCL5 (Fig. 4C). Here, CCL5 is linked to gastric cancer.